Search results for "adrenal cortex hormones"

showing 10 items of 145 documents

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study

2016

AIM To evaluate the real-world effectiveness of golimumab in ulcerative colitis (UC) and to identify predictors of response. METHODS We conducted an observational, prospective and multi-center study in UC patients treated with golimumab, from September 2014 to September 2015. Clinical activity was assessed at wk 0 and 14 with the physician' s global clinical assessment (PGA) and the partial Mayo score. Colonoscopies and blood tests were performed, following daily-practice clinical criteria, and the results were recorded in an SPSS database. RESULTS Thirty-three consecutive patients with moderately to severely active UC were included. Among them, 54.5% were female and 42 years was the averag…

AdultMalemedicine.medical_specialtyTime FactorsAnti-Inflammatory AgentsObservational StudySeverity of Illness IndexGolimumab03 medical and health sciences0302 clinical medicineGastrointestinal AgentsAdrenal Cortex HormonesInternal medicineHumansMedicineProspective StudiesTumor Necrosis Factor-alphabusiness.industryRemission InductionGastroenterologyAntibodies MonoclonalColonoscopyGeneral MedicineMiddle Agedmedicine.diseaseReal-life resultsUlcerative colitisdigestive system diseasesGolimumabTreatment OutcomeMulticenter studyUlcerative colitisSpain030220 oncology & carcinogenesisColitis UlcerativeDrug Therapy CombinationFemale030211 gastroenterology & hepatologyObservational studybusinessmedicine.drug
researchProduct

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the lit…

2018

This review provides an overview of the role of long-term treatment of severe asthma with oral corticosteroids (OCS) and its associated side-effects in adults. It is based on a systematic literature search conducted in MEDLINE, Embase and the Cochrane Library to identify relevant studies. After a short overview of severe asthma and its treatment we present studies showing a dose–response relationship in asthmatic patients treated with OCS and then consider by organ systems the undesired effects demonstrated in clinical and epidemiological studies in patients with OCS-dependent asthma. It was found that the risk of developing various OCS-related complications, including infections, diabetes …

AdultPulmonary and Respiratory Medicinemedicine.medical_specialtySevere asthmaOsteoporosisMEDLINEAdministration OralCochrane Library03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesDiabetes mellitusHealth careEpidemiologymedicineHumans030212 general & internal medicineIntensive care medicineRandomized Controlled Trials as TopicAsthmaDose-Response Relationship Drugbusiness.industrymedicine.diseaseAsthma030228 respiratory systembusinessEuropean Respiratory Journal
researchProduct

Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

2001

The prevalence and pattern of cognitive impairment in systemic lupus erythematosus (SLE) patients with (NPSLE) and without (nSLE) overt neuropsychiatric manifestations were investigated. Fifty-two nSLE patients, 23 NPSLE patients and 27 healthy controls were evaluated with a battery of standardized neuropsychological and psychological tests. Disease duration, disease activity index, and current corticosteroid therapy were collected. Cognitive impairment was identified in 14 (26.9%) and in 12 (52.2%) of subjects with nSLE and NPSLE, respectively. Both SLE groups showed a significant impairment compared with controls on tasks assessing verbal and non-verbal long-term memory, and visuoconstruc…

Adultmedicine.medical_specialtyAnxietyNeuropsychological TestsMental ProcessesAdrenal Cortex HormonesMemoryInternal medicinemedicineHumansLupus Erythematosus SystemicSpeechSystemic lupus erythematosus Neuropsychiatric SLE Cognitive impairment Neuropsychology DepressionAttentionPsychological testingEffects of sleep deprivation on cognitive performanceDepression (differential diagnoses)Psychiatric Status Rating ScalesLupus erythematosusDepressionCognitive disorderNeuropsychologymedicine.diseaseConnective tissue diseaseMemory Short-TermNeurologyMental RecallPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)Cognition DisordersPsychologyPsychomotor PerformancePsychopathologyJournal of the Neurological Sciences
researchProduct

Treatment of cutaneous lupus erythematosus: current practice variations

2015

The treatment of cutaneous lupus erythematous (CLE) remains a challenge. Most of the therapeutic options used in CLE have not been tested in randomized controlled studies and to date no agent has been approved. Therefore, CLE treatment is mostly based on personal experience. To better characterize therapeutic habits among physicians treating CLE patients, a questionnaire-based study about various aspects of topical and systemic treatment for CLE has been performed. The questionnaire was distributed among CLE experts, mostly from Japan, the USA, and Europe. A total of 82 completed questionnaires were assessed. High-potent and potent corticosteroids as well as calcineurin inhibitors were the…

Adultmedicine.medical_specialtyCalcineurin InhibitorsDiseaseControlled studiesSystemic therapyAntimalarials030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineJapanRheumatologyAdrenal Cortex HormonesSurveys and QuestionnairesLupus Erythematosus CutaneousmedicineHumansPractice Patterns Physicians'Aged030203 arthritis & rheumatologybusiness.industryfungiTreatment optionsMiddle AgedDermatologyUnited StatesEuropeCalcineurinTreatment OutcomeCurrent practiceConcomitantImmunologyCutaneous Lupus ErythematosusbusinessLupus
researchProduct

The Treatment of Mild and Moderate Asthma in Adults

2020

BACKGROUND: Asthma is a chronic inflammatory airway disease that usually causes variable airway obstruction. It affects 5–10% of the German population. METHODS: This review is based on relevant publications retrieved by a selective search, as well as on national and international guidelines on the treatment of mild and moderate asthma in adults. RESULTS: The goal of treatment is to attain optimal asthma control with a minimal risk of exacerbations and mortality, loss of pulmonary function, and drug side effects. This can be achieved with a combination of pharmacotherapy and non-drug treatment including patient education, exercise, smoking cessation, and rehabilitation. Pharmacohterapy is ba…

Adultmedicine.medical_specialtyContinuing Medical EducationModerate asthma03 medical and health sciences0302 clinical medicinePharmacotherapyGerman populationimmune system diseasesAdrenal Cortex HormonesFormoterol FumarateInternal medicineAdministration InhalationmedicineHumansAnti-Asthmatic Agents030212 general & internal medicineAsthmaInhalationbusiness.industryGeneral Medicinerespiratory systemAirway obstructionmedicine.diseaseAsthmarespiratory tract diseasesAirway disease030228 respiratory systemDrug Therapy CombinationFormoterol FumaratebusinessDeutsches Ärzteblatt international
researchProduct

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission.…

2019

Abstract To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months. To further evaluate the rate of patients maintaining the remission and the rate of CCSs discontinuation, after additional 12 months of follow-up. A retrospective evaluation of patients prospectively followed was designed to compare the rate of clinical remission in naïve AOSD patients treated with high dosages of CCSs (0.8–1 mg/kg/day of prednisone-equivalent) or low dosage of CCSs (0.2–0.3 mg/kg/day of prednisone-equivalent), after 6 months. An add…

Adult-OnsetMalePediatricsAdult-onset Still's diseaseDiseaseAdrenal Cortex Hormonecorticosteroids0302 clinical medicinemonocyclic patternAdrenal Cortex HormonesRetrospective StudieMedicine030212 general & internal medicineProspective StudiesProspective cohort studyRemission InductionDisease ManagementGeneral MedicineMiddle AgedTreatment OutcomeHigh dosage030220 oncology & carcinogenesisFemaleDrugStill's Disease Adult-OnsetResearch ArticleHumanAdultcorticosteroidmedicine.medical_specialtyLow dosageObservational StudyAdult-onset Still's diseaseFollow-Up StudieDose-Response Relationship03 medical and health sciencesremissionAdult-onset Still's disease; corticosteroids; first-line therapy; monocyclic pattern; remission; Adrenal Cortex Hormones; Adult; Disease Management; Dose-Response Relationship Drug; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Retrospective Studies; Still's Disease Adult-Onset; Treatment Outcomefirst-line therapyHumansRetrospective StudiesDose-Response Relationship Drugbusiness.industry6900Retrospective cohort studyStill's DiseaseFirst line treatmentSettore MED/16 - ReumatologiaProspective StudieMethotrexateObservational studybusinessFollow-Up Studies
researchProduct

Effect of rat plasma high density lipoprotein with or without apolipoprotein E on the cholesterol uptake and on the induction of the corticosteroid b…

1991

Abstract High density lipoprotein (HDL) has been shown to induce the cellular accumulation of cholesterol esters and the biosynthesis of 21-hydroxysteroids (corticosteroids) newborn rat adrenocortical cells cultivated in serum-free medium. In order to identify the component(s) of HDL responsible for these effects, we investigated the ability of rat HDL subfractions and HDL with or without apolipoprotein E to deliver cholesterol to cells and to stimulate the steroid biosynthetic pathways in adrenal cultured cells. The total cholesterol uptake from HDL 2 was greater than that observed with HDL rich in apolipoprotein E (HDL 1 and HDL c ). Furthermore, the increase of the ratio between 21-hydro…

Apolipoprotein Emedicine.medical_specialtyApolipoprotein Bmedicine.medical_treatmentBiologySteroidMicechemistry.chemical_compoundApolipoproteins EHigh-density lipoproteinBiosynthesisAdrenal Cortex HormonesCorticosteroneInternal medicinemedicineAnimalsMolecular BiologyCells CulturedCholesterolnutritional and metabolic diseasesCell BiologyRatsLipoproteins LDLCholesterolEndocrinologyAnimals NewbornchemistryAdrenal Cortexbiology.proteinlipids (amino acids peptides and proteins)Apolipoprotein C2Lipoproteins HDLBiochimica et Biophysica Acta (BBA) - Molecular Cell Research
researchProduct

Auto-immune haemolytic anaemia in ulcerative colitis: report of three cases.

1994

Autoimmune diseaseHemolytic anemiaAdultMalebusiness.industryHematologyGeneral Medicinemedicine.diseaseAuto immuneUlcerative colitisAdrenal Cortex HormonesImmunopathologyImmunologymedicineSplenectomyHumansColitis UlcerativeFemaleAnemia Hemolytic AutoimmuneYoung adultComplicationbusinessColectomyImmunosuppressive AgentsActa haematologica
researchProduct

Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.

2017

Abstract Although the better management of rheumatoid arthritis (RA) has significantly improved the long-term outcome of affected patients, a significant proportion of these may develop associated comorbidities including cardiometabolic complications. However, it must be pointed out that a comprehensive cardiometabolic evaluation is still poorly integrated into the management of RA patients, due to a limited awareness of the problem, a lack of appropriate clinical studies, and optimal strategies for cardiovascular (CV) risk reduction in RA. In addition, although several studies investigated the possible association between traditional CV risk factors and RA, conflicting results are still av…

Blood GlucoseMalerheumatoid arthritisTime FactorsCross-sectional studyType 2 diabetesAdrenal Cortex HormoneBody Mass IndexArthritis Rheumatoid0302 clinical medicineimpaired fasting glucoseAdrenal Cortex HormonesRisk FactorsRheumatoidCardiovascular DiseasePrevalence030212 general & internal medicineMedicine (all)Diabetes MellituGeneral MedicineMiddle AgedC-Reactive ProteinCholesterolcardiovascular risk; impaired fasting glucose; inflammation; rheumatoid arthritis; type 2 diabetes;Cardiovascular DiseasesCohortHypertensionFemaletype 2 diabetesCase-Control Studiecardiovascular risk; impaired fasting glucose; inflammation; rheumatoid arthritis; type 2 diabetes; Adrenal Cortex Hormones; Adult; Aged; Arthritis Rheumatoid; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cross-Sectional Studies; Diabetes Mellitus Type 2; Female; Glucose Intolerance; Humans; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; Time Factors; Medicine (all)Type 2Research ArticleArthritiHumanAdultcardiovascular riskmedicine.medical_specialtyTime FactorObservational StudyNO03 medical and health sciencesInternal medicineDiabetes mellitusGlucose Intolerancemedicinecardiovascular risk impaired fasting glucose inflammation rheumatoid arthritis type 2 diabetesHumansAged030203 arthritis & rheumatologyCross-Sectional Studietype 2 diabetebusiness.industryRisk Factor6900Case-control studyrheumatoid arthritimedicine.diseaseImpaired fasting glucoseSettore MED/16 - ReumatologiaCross-Sectional StudiesDiabetes Mellitus Type 2inflammationCase-Control StudiesMetabolic syndromebusinessBody mass index
researchProduct

Plasma corticosteroids, free fatty acids, insulin and glucose in maternal blood during delivery.

1970

Plasma-corticosteroids (PCS), free fatty acids (FFA), insulin and glucose were determined continously in maternal blood during the entire course of delivery, from the first stage of labour until 6 hours after delivery. A steep increase in the PCS and FFA concentration could be noticed from the onset of labour (PCS: 37,8±11.2 µg/100 ml;\(s_{\bar x} \),p≦0.01; FFA: 556±106.6 µVal/l;\(s_{\bar x} \),p≦0.01) to the birth of the child (PCS: 96.8±19,5 µg/100 ml;\(s_{\bar x} \),p≦0.01; FFA: 1129±220 µVal/l;\(s_{\bar x} \),p≦0.01) and basal levels were already reached 6 hours later (PCS: 36.0±18.5 µg/100 ml;\(s_{\bar x} \),p≦0.01; FFA: 538±192.8 µVal/l;\(s_{\bar x} \),p≦0.01). The rise of insulin an…

Blood Glucosemedicine.medical_specialtyLabor ObstetricChemistryInsulinmedicine.medical_treatmentGeneral MedicineMaternal bloodFatty Acids NonesterifiedDelivery ObstetricEndocrinologyAdrenal Cortex HormonesPregnancyStress PhysiologicalInternal medicineEndocrine GlandsDrug DiscoverymedicineMolecular MedicineHumansInsulinFemaleGenetics (clinical)Nervous controlKlinische Wochenschrift
researchProduct